双歧杆菌三联活菌肠溶胶囊对便秘型肠易激综合征患者胃肠激素及氧化应激指标的影响

doi:10.3969/j.issn.1004-583X.2019.07.012

临床荟萃

双歧杆菌三联活菌肠溶胶囊对便秘型肠易激综合征患者胃肠激素及氧化应激指标的影响

1.上海市浦东新区周浦医院消化内科，上海 201318；2.上海市浦东新区人民医院消化内科，上海 201200

出版日期:2019-07-20 发布日期:2019-08-24
通讯作者: 高泽立， Email：gzeli@163.com

Effects of Bifidobacterium triple viable entericcoated capsules on gastrointestinal hormones

1.Department of Gastroenterology, Zhoupu Hospital of Shanghai, Shanghai 2013182，China;
2.Department of Gastroenterology, Pudong New District People's Hospital Affiliated to
Shanghai Medical College of Health, Shanghai 201200, China

Online:2019-07-20 Published:2019-08-24
Contact: Corresponding author: Gao Zeli, Email：gzeli@163.com

摘要/Abstract

摘要： 目的研究双歧杆菌三联活菌肠溶胶囊对便秘型肠易激综合征（IBSC）患者症状评分、胃肠激素及氧化应激指标的影响。方法选择2018年112月在上海市浦东新区周浦医院治疗的IBSC患者94例。用随机数表法分为对照组（n=47）和观察组（n=47），两组给予莫沙必利联合乳果糖治疗，观察组加用双歧杆菌三联活菌肠溶胶囊治疗，对照组加用安慰剂。比较两组的临床疗效、临床症状、胃肠激素、5羟色胺（5HT）及氧化应激指标。结果观察组显效29例（61.70%），有效15例（31.91%），总有效率为93.62%，对照组仅为78.72%（P＜0.05）。治疗后两组临床症状评分明显下降，观察组腹胀腹痛、排便频率、大便性状和排便困难评分明显低于对照组（P＜0.05）。治疗后两组5HT、丙二醛（MDA）和脂质过氧化物（LPO）水平明显下降，观察组5HT、MDA和LPO水平低于对照组（P＜0.05）。治疗后两组胃肠激素水平均有所改善，观察组胃动素（MTL）水平高于对照组，血管活性肠肽（VIP）和生长抑素（SS）水平低于对照组（P＜0.05）。结论双歧杆菌三联活菌胶囊联合乳果糖、莫沙必利治疗IBSC的疗效显著，能够明显改善患者的临床症状和胃肠激素水平，降低血浆5HT水平，并减轻氧化应激反应，值得在临床推广应用。

关键词: 肠易激综合征, 双歧杆菌三联活菌肠溶胶囊, 5羟色胺, 氧化应激

Abstract: Objective To study the effects of Bifidobacterium triple viable entericcoated capsules on symptoms score, gastrointestinal hormones and oxidative stress index in irritable bowel syndromeconstipation（IBSC） patients. Methods A total of 94 patients with IBSC treated in our hospital from January 2018 to December 2018 were selected, and they were randomly divided into control group(n=47) and observation group(n=47). The two groups of patients were treated with mosapride in combination with lactulose, with observation group added with Bifidobacterium triple live enteric capsules, and control group added with placebo. The clinical efficacy, clinical symptoms, gastrointestinal hormones, 5HT and oxidative stress were compared between two groups.Results In observation group, the treatment was markedly effective in 29 cases (61.70%), and effective in 15 cases (31.91%), with the total effective rate being 93.62%, and that of control group being 78.72%(P<0.05). After treatment, the scores of clinical symptoms in two groups decreased significantly. The scores of abdominal distension, abdominal pain, defecation frequency, stool characteristics and defecation difficulty in observation group were significantly lower than those in control group (P<0.05). After treatment, the levels of 5HT, MDA and LPO in two groups also witnessed significance decrease. The levels of 5HT, MDA and LPO in observation group were lower than those in control group (P<0.05). After treatment, the levels of gastrointestinal hormones in both groups were improved. The MTL level in observation group was higher than that in control group, and the levels of VIP and S S were lower than those in control group (P<0.05). Conclusion Bifidobacterium triple viable capsule combined with lactulose and Mosapride is effective in treatment of IBSC. It can significantly improve clinical symptoms and gastrointestinal hormone levels, reduce plasma 5HT level and oxidative stress response, which makes it is worthy of clinical application.

Key words: irritable bowel syndrome, Bifidobacterium triple viable entericcoated capsules, 5hydroxytryptamine, oxidative stress

张成1，高泽立2. 双歧杆菌三联活菌肠溶胶囊对便秘型肠易激综合征患者胃肠激素及氧化应激指标的影响[J]. 临床荟萃, doi: 10.3969/j.issn.1004-583X.2019.07.012.

Zhang Cheng1，Gao Zeli2. Effects of Bifidobacterium triple viable entericcoated capsules on gastrointestinal hormones[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2019.07.012.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2019.07.012

https://huicui.hebmu.edu.cn/CN/Y2019/V34/I7/629

[1]	吕丽丽, 翟满满, 丁小艳, 陈永清. 线粒体转录因子A介导的线粒体功能障碍在糖尿病心肌病中的作用[J]. 临床荟萃, 2023, 38(5): 465-468.
[2]	宋怡然, 梁笑楠, 李忱阳, 张晓岚. 《2020年中国肠易激综合征专家共识意见》解读[J]. 临床荟萃, 2021, 36(7): 628-631.
[3]	肖文静, 罗和生. 瞬时受体电位家族在肠易激综合征中的作用机制研究进展[J]. 临床荟萃, 2021, 36(5): 467-470.
[4]	刘亭, 姬卫东, 杨青松. 脑蛋白水解物对急性脑卒中患者Nrf2氧化应激信号通路的影响[J]. 临床荟萃, 2021, 36(11): 996-1000.
[5]	周园媛1，王战建2，丘红梅1，李薇1. 2型糖尿病肾病与血清胆红素的关系[J]. 临床荟萃, 2017, 32(9): 767-769,773.
[6]	杨露, 袁雅冬. PM_2.5的氧化损伤机制及其与呼吸系统疾病关系[J]. 临床荟萃, 2016, 31(4): 433-438.
[7]	常庚;孙晓培;孙大勇;雷阳;李明;韩杰. 肌萎缩侧索硬化患者血清氧化标记物表达水平与病情严重程度的相关性分析[J]. 临床荟萃, 2014, 29(8): 856-857858.
[8]	李一梅;刘宽芝. 氧化应激、线粒体功能障碍与2型糖尿病[J]. 临床荟萃, 2014, 29(2): 213-216.
[9]	王丹萍;李亚迪;任辉;沈晓伶;黄志刚. 脑磁共振成像技术在肠易激综合征中的应用[J]. 临床荟萃, 2014, 29(12): 1429-1431.
[10]	郑秀丽;符雪松;王玉刚;张艳华;赵侠;李红寅. 奥替溴铵联合益生菌治疗腹泻型肠易激综合征疗效[J]. 临床荟萃, 2014, 29(10): 1168-1170.
[11]	邢邯英;刘敏;野战鹰;张冬会. 正铁血红素改善链脲佐菌素诱导的糖尿病大鼠肝损伤[J]. 临床荟萃, 2014, 29(1): 56-58.
[12]	梁育飞;田树英. 氟哌塞吨美利曲辛联合双歧杆菌四联活菌治疗腹泻型肠易激综合征患者免疫指标的变化及意义[J]. 临床荟萃, 2013, 28(5): 559-561.
[13]	田树英;郑国启;魏思忱;石亮;孙鑫义. 腹泻型肠易激综合征患者的生活质量和心理特征分析[J]. 临床荟萃, 2013, 28(10): 1087-1089.
[14]	谢建军;杨英姿;李亚洁;朱欣佚. 斋月前后糖尿病患者氧化应激的变化[J]. 临床荟萃, 2013, 28(1): 83-85.
[15]	潘晨;杨杰;张永宏. 足三里电刺激辅助治疗便秘型肠易激综合征的疗效观察[J]. 临床荟萃, 2012, 27(17): 1545-1547.

双歧杆菌三联活菌肠溶胶囊对便秘型肠易激综合征患者胃肠激素及氧化应激指标的影响

Effects of Bifidobacterium triple viable entericcoated capsules on gastrointestinal hormones

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价